Posters
Hammer J, F Hochleitner, DH Seewald, J Meindl, W Labeck:
HDR Ir-192 implantations into the vocal cord in the organ-preserving management of larynx cancer: method and preliminary results.
5th European Conference on Clinical Oncology (ECCO 5), London, UK, 3-7 September 1989.
Hammer J, DH Seewald, JP Zoidl, W Labeck:
Preliminary results of a 4-year experience in HDR Ir-192 implants in breast cancer therapy.
5th European Conference on Clinical Oncology (ECCO 5), London, UK, 3-7 September 1989.
Pakisch B, J Hammer, H. Leitner, Ch Track, B Poschauko, A Hackl:
Klinische Fehlinterpretationen nach brusterhaltendem Therapiekonzept.
Mammakarzinom - State of the Art, 10. Jahrestagung der Österreichischen Gesellschaft für Senologie und ACO-Schwerpunktsymposium (gemeinsam mit der CAO), Salzburg, 30.9. - 2.10. 1993.
Hammer J:
External beam and HDR intracavitary irradiation: An effective tool in the primary treatment of cancer of the uterine cervix-excellent 10 year results and low side effects.
38th ASTRO, Los Angeles, Ca, USA, 27.-30. 10.1996
Löw H, Gruy B, Hammer J:
Deviations of mechanical arc-stability during Linac based stereotaxy.
ISRS, Madrid, Spanien, September 1997
Tschurtschenthaler G, P Oppitz, J Hammer, P Flink, M Fridrik and G Michlmayr:
The effect of medical information on women´s opinion about breast cancer.
Internat. Conference on Adjuvant Therapy of Primary Breast Cancer, St.Gallen, 25.-28. Feb. 1998
Hammer J et al:
Breast cancer-external beam radiotherapy and interstitial iridium implantation-10 year clinical results.
Internat. Conference on Adjuvant Therapy of Primary Breast Cancer, St.Gallen, 25. – 28. Feber 1998
Hammer J et al.:
Breast cancer-external beam radiotherapy and interstitial iridium implantation-10 year clinical results.
6.Internat. Meeting on Progress in Radiation Oncology ICRO/ÖGRO, Salzburg, 13.-18. May 1998
Hammer J, Track C, Seewald D H, Zoidl J P, Labeck W, Putz E, Gruy B:
The influence of breast tumour location on survival and cosmesis (644 patients, 1984 - 1995).
16. Jahrestagung, Österreichische Gesellschaft für Senologie, Baden bei Wien, 14.-16 Oct. 1999
Hammer J, Track C, Bayerl A, Seewald D H, Feichtinger J, Stranzl H, Posch A, Spiegl K:
A comparison of different boost types in breast conserving therapy (BCT): retrospective considerations.
46th ASTRO 2004, Atlanta, Georgia, USA, 2.-7. Oktober 2004
Huppert-Holzmeister R, Aichholzer M, Schindler C, Pichler J, Hammer J:
Kleinzelliges neurogenes Sarkom-eine interdisziplinäre Herausforderung (Fallbericht). ÖGRO Jahrestagung, Wien, 15. -16. Oktober 2004
Feichtinger J, C Venhoda, K Spiegl, W Langsteger, M Heinisch, S Haim, J Hammer:
18 F Cholin PET-CT zur Bestrahlungsplanung bei biochemischem Rezidiv nach radikaler Prostatektomie.
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizer Gesellschaften für Nuklearmedizin, Basel 27-30. 4. 2005
Hammer J, Track C, Spiegl K, Thames HD:
Recursive partitioning analysis in breast cancer patients treated by adjuvant whole breast radiotherapy followed by external beam boost or brachytherapy boost: prognostic groups in 1485 patients.
5th European Breast Cancer Conference, Nice, France, 21-25 März 2006.
Hammer J, Track Ch, Thames HD:
Recursive partitioning analysis in breast cancer patients treated by adjuvant whole breast radiotherapy followed by external beam boost or brachytherapy boost: prognostic groups in 1485 patients.
12. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), Dresden, 25.-28. Mai 2006.
Ott O, G Hildebrandt, R Pötter, J Hammer, M Lotter, Alexandra Resch, R Sauer, V Strnad :
Akzelerierte Teilbrustbestrahlung: Zwischenergebnisse der Deutsch-Österreichischen Phase-II-Studie.
26. Jahrestagung der Deutschen Gesellschaft für Senologie, Dresden, 31. August-2. September 2006.
Ausgezeichnet mit dem Wissenschaftspreis (1. Preis) der DGS für wissenschaftliche Originalarbeiten.
Hammer J, Track C, Petzer A, Thames HD, Pöstlberger S:
Age-based prognostic factors for 1347 breast cancer patients treated with breast conservation surgery and adjuvant radiotherapy.
ESTRO 25th Annual Meeting, Leipzig, 8. – 12. October 2006.
Hammer J, Track C , Petzer AL, Thames HD, Pöstlberger S:
Prognostic groups in node-negative and node-positive breast cancer patients treated by adjuvant radiotherapy: a recursive partitioning analysis (RPA) based on 1347 patients.
ASTRO 48th Annual Meeting. Philadelphia, PA, 7. – 10. November 2006.
Ott O, G Hildebrandt, R Pötter, J Hammer, M Lotter, Alexandra Resch, R Sauer, V Strnad :
Partial breast irradiation with 192-Iridium implants after brest conserving surgery: updated results of the German-Austrian Phase II-Trial.
GEC-ESTRO-ISIORT Meeting, Montpellier, France, 9.-12.5.2007.
Hammer J, Track Ch, Thames HD:
Risk analysis in breast cancer patients after treatment by adjuvant whole breast radiotherapy followed by a boost: prognostic groups in 1238 patients.
8th International Meeting on Progress in Radio-Oncology-ICRO/ÖGRO 8, 16.-19. 5. 2007, Salzburg, Austria.
Hammer J, DH Seewald, K Spiegl:
Radiotherapy in Local Advanced Prostate Cancer Patients.
Salzburger-Oberösterreichisches Urologentreffen, 29. Jan. 2008, Ried im Innkreis, Austria.
Hammer J, C Track, DH Seewald, J Feichtinger, HD Thames, AL Petzer, W Langsteger, KJ Spiegl, S Pöstlberger, E Bräutigam:
Persisting risk after BCT in N+ and N- patients: a single institution analysis from 1485 patients.
6 th European Breast Cancer Conference (EBCC 6), 15-19 April 2008, Berlin, Germany.
Hammer J, C Track, KJ Spiegl, HD Thames, DH Seewald, J Feichtinger, AL Petzer, M Beheshti, S Pöstlberger, E Bräutigam:
Breast Tumor Location and the Impact of Nodal Status on Local Recurrence (LR) and Disease Free Survival (DFS).
ASTRO 2010, 52nd Annual Meeting, Oct 31 – Nov 4, 2010, San Diego, California
Hammer J, Track C, KJ Spiegl, HD Thames, DH Seewald, J Feichtinger, AL Petzer, D Heck, E Rechberger, M Beheshti, H-C Bösmüller, E Bräutigam:
What have we learned from recursive partitioning analyses in breast cancer patients? A single institution report on more than 2000 patients.
8th European Breast Cancer Conference Vienna, (EBCC 8), 21. – 24. March, 2012.
Hammer J, Track C, KJ Spiegl, HD Thames, DH Seewald, W Labeck, E Putz, E Bräutigam:
Breast cancer: external beam radiotherapy and interstitial boost application - an analysis of 1065 patients.
ESTRO 31, Barcelona, 9.-13. May 2012.
Hammer J, Track C, KJ Spiegl, HD Thames, DH Seewald, J Feichtinger, AL Petzer, D Heck, M Beheshti, E Bräutigam:
Nodal Status and Tumor Location-an Unorthodox Relationship in Breast Cancer Patients.
American Society for Radiation Oncology (ASTRO) 54th Annual Meeting, 28.-31. October 2012, Boston, MA, USA. Abstract 2056: Proceedings of the American Society for Radiation Oncology 54th Annual Meeting, 28-31 October 2012, Int J Radiat Oncol Biol Phys November 1, 2012, Volume 84, Issue 3, Supplement, Pages S239–S240
Bräutigam E, Track C, J Hammer, H Geinitz:
Hypofractionated RT of the breast - experience with 500 women.
ESTRO 33 Wien, 4. – 8. April 2014.
Gruber G, Track C, C Venhoda, J Hammer, B Spindelbalker-Renner, E Putz, KJ Spiegl, H Geinitz:
Radiotherapy of anal cancer: Is IMRT and VMAT a step forward?
ESTRO 33 Wien 4. – 8. April 2014.
Springer A, E Winkler, E Putz, A Altenburger, R Gruber, K Moser, C Track, J Hammer, H Geinitz:
Dose planning of a total body irradiation with Volumetric Modulated Arc Therapy (VMAT).
ESTRO 33 Wien, 4. – 8. April 2014
Track C, Hammer J, A Springer, E Winkler, A Weltermann, A Böhm, H Kasparu, A Altenburger, R Gruber, H Geinitz:
The introduction of volumetric modulated arc therapy to total body irradiation (TBI)-first experiences.
ESTRO 33 Wien 4. – 8. April 2014
Kocik L, C. Track, J Feichtinger, J Kaufmann, J Hammer, H. Geinitz:
Short-Course Hyperfractionated Accelerated Radiation Therapy (SC-HART) for Rectal Cancer Stage UICC II – III (8th Edition). Results from a Single Austrian Institution.
Int J Radiat Oncol Biol Phys. 102(3):e9 Nov 2018. doi: 10.1016/j.ijrobp.2018.07.212